Fast Locator 2011-2012: Lonza - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Fast Locator 2011-2012: Lonza



A HISTORY OF INNOVATION
In 1897, Lonza was founded on the banks of the river Lonza in the Swiss Alps by adventurous entrepreneurs. Today, Lonza continues to embody that pioneering spirit as a leading innovator and partner for the pharmaceutical, healthcare, nutrition, personal care, cosmetic, industrial biotech and life science industries.

PROVEN TRACK RECORD
For over 25 years, Lonza Custom Manufacturing has been helping emerging and large biotechnology and pharmaceutical companies improve and advance their products. Whether for clinical or commercial supply, Lonza’s complete set of development services, industry-leading manufacturing processes, and broad chemical and biotechnology platforms enable your products to reach their full potential.

EXTENSIVE CAPABILITIES & EXPERIENCE
Active pharmaceutical ingredients (APIs), highly potent APIs, advanced intermediates, fine chemicals, nutraceuticals, cosmeceuticals, antibody drug conjugates, peptides, vaccines, plasmid DNA, recombinant novel proteins, monoclonal antibodies, antibody fragments, cell-based therapeutics, research products and media services … Lonza has the know-how and experience to handle almost any pharmaceutical or biotechnology challenge, around the globe.


COMPLETE PROCESS R&D SERVICES:

  • AggreSolve Protein Aggregation Predictor
  • The GS Gene Expression System
  • XS Microbial Expression Technologies
  • Cell line construction
  • Strain design
  • Bio/catalyst design
  • Process development
  • Process scale-up
  • Process validation
  • Process transfer
  • Technology development
  • Regulatory support

WORLDWIDE, STATE-OF-THE-ART FACILITIES
North America: Portsmouth, NH; Hopkinton, MA; Walkersville, MD
Europe: Slough, UK; Kourim, CZ; Porrino, ES; Braine, BE; Verviers, BE
Asia: Nansha, CN; Singapore, SG


Contact:

Lonza
Muenchensteinerstr. 38
CH-4002 Basel
Switzerland
+41 61 316 8111
contact@lonza.com

Website:

www.lonza.com

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality

Click here